Mesa and Ulmer Measure Methods for JAK Inhibitor Optimization in Myelofibrosis

MPN Education Foundation/MPN-NET Speaker Event – Thursday, September 10th, 2020

The MPN EDUCATION FOUNDATION and MPN-NET presented a patient event hosted by Dr. Ruben Mesa, with guest presentations from Dr. Claire Harrison, Aaron Gerds and John Mascarenhas.

Dr. Mesa and Antje Hjerpe discuss Treatment for ET

Myeloproliferative Neoplasma (MPNs) Update – Spring 2020

Participate in Studies

Trouble sleeping?

This trial aims to study the effectiveness of two different wellness-based mobile apps on blood cancer patient outcomes, including sleep, fatigue, anxiety, depression, and blood biomarkers of inflammation (TNF-a, IL-6, IL-8, CRP). The findings of this study may help physicians and researchers better understand how mobile wellness apps can help manage symptom burden and inflammation in blood cancer patients.  Check to see if you can participate: Wellness App for Sleep Disturbance in Hematological Cancer Patients

FDA Approval of Fedratinib – Dr. Mesa answers your questions

MPN 2019 Summer Update – Dr Mesa and Dr Scherber

“Cancer is a Thief” – Ruben Mesa, M.D., FACP

John Mascarenhas discusses MDS/MPN overlap for patients